{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:31:44Z","timestamp":1769009504400,"version":"3.49.0"},"reference-count":27,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Novel small molecule inhibitors of the oxytocin receptor (OTR) may have distinct pharmacology and mode of action when compared with first-generation oxytocin antagonists when used for the prevention of preterm birth. The aim was to determine the mechanism of action of small molecule OTR antagonists retosiban and epelsiban compared with the currently used peptide-based compound atosiban. Human myometrial samples were obtained at cesarean section and subjected to pharmacological manipulations to establish the effect of antagonist binding to OTR on downstream signaling. Retosiban antagonism of oxytocin action in human myometrium was potent, rapid, and reversible. Inhibition of inositol 1,4,5-trisphosphate (IP3) production followed single-site competitive binding kinetics for epelsiban, retosiban, and atosiban. Retosiban inhibited basal production of IP3 in the absence of oxytocin. Oxytocin and atosiban but not retosiban inhibited forskolin, and calcitonin stimulated 3\u2032,5\u2032-cyclic adenosine 5\u2032-mono-phosphate (cAMP) production. Inhibition of cAMP was reversed by pertussis toxin. Oxytocin and atosiban, but not retosiban and epelsiban, stimulated extracellular regulated kinase (ERK)1\/2 activity in a time- and concentration-dependent manner. Oxytocin and atosiban stimulated cyclo-oxygenase 2 activity and subsequent production of prostaglandin E2 and F2\u03b1. Prostaglandin production was inhibited by rofecoxib, pertussin toxin, and ERK inhibitor U0126. Oxytocin but not retosiban or atosiban stimulated coupling of the OTR to G\u03b1\u200aq G-proteins. Oxytocin and atosiban but not retosiban stimulated coupling of the OTR to G\u03b1\u200ai G-proteins. Retosiban and epelsiban demonstrate distinct pharmacology when compared with atosiban in human myometrial smooth muscle. Atosiban displays agonist activity at micromolar concentrations leading to stimulation of prostaglandin production.<\/jats:p>","DOI":"10.1210\/endocr\/bqz043","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T05:54:31Z","timestamp":1578376471000},"source":"Crossref","is-referenced-by-count":5,"title":["Functionally Selective Inhibition of the Oxytocin Receptor by Retosiban in Human Myometrial Smooth Muscle"],"prefix":"10.1210","volume":"161","author":[{"given":"Paul J","family":"Brighton","sequence":"first","affiliation":[{"name":"Cell and Developmental Biology, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick CV2 2DX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Fossler","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Upper Merion West, King of Prussia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3221-5471","authenticated-orcid":false,"given":"Siobhan","family":"Quenby","sequence":"first","affiliation":[{"name":"Cell and Developmental Biology, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick CV2 2DX, UK"},{"name":"Maternity Directorate, University Hospital Coventry and Warwickshire, Coventry CV2 2DX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-6081","authenticated-orcid":false,"given":"Andrew M","family":"Blanks","sequence":"first","affiliation":[{"name":"Cell and Developmental Biology, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick CV2 2DX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"2020022511493573400_CIT0001","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health."},{"issue":"9606","key":"2020022511493573400_CIT0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet."},{"key":"2020022511493573400_CIT0003","first-page":"4","article-title":"Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study","year":"2013"},{"issue":"1","key":"2020022511493573400_CIT0004","first-page":"95","article-title":"Economic burden of hospitalizations for preterm labor in the United States","volume":"96","author":"Nicholson","year":"2000","journal-title":"Obstet Gynecol."},{"issue":"5","key":"2020022511493573400_CIT0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1381612825666190329124214","article-title":"Safety and efficacy of tocolytics for the treatment of spontaneous preterm labour","volume":"25","author":"Lamont","year":"2019","journal-title":"Curr Pharm Des."},{"issue":"4","key":"2020022511493573400_CIT0006","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","article-title":"Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J Neuroendocrinol."},{"key":"2020022511493573400_CIT0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-0528.2003.00024.x","article-title":"The role of oxytocin in parturition","volume":"110","author":"Blanks","year":"2003","journal-title":"Bjog."},{"key":"2020022511493573400_CIT0008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-4871-3_35","article-title":"Molecular mechanisms regulating the effects of oxytocin on myometrial intracellular calcium","volume":"449","author":"Sanborn","year":"1998","journal-title":"Adv Exp Med Biol."},{"issue":"Mar 5","key":"2020022511493573400_CIT0009","first-page":"64","article-title":"Oxytocin activates NF-\u03baB-mediated inflammatory pathways in human gestational tissues","volume":"403","author":"Kim","year":"2015","journal-title":"Mol Cell Endocrinol."},{"issue":"Jan 15","key":"2020022511493573400_CIT0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2015.11.012","article-title":"The oxytocin receptor antagonist, Atosiban, activates pro\u2013inflammatory pathways in human amnion via G(\u03b1i) signalling","volume":"420","author":"Kim","year":"2016","journal-title":"Mol Cell Endocrinol."},{"issue":"1","key":"2020022511493573400_CIT0011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bmcl.2007.11.008","article-title":"The discovery of GSK221149A: a potent and selective oxytocin antagonist","volume":"18","author":"Liddle","year":"2008","journal-title":"Bioorg Med Chem Lett."},{"issue":"1","key":"2020022511493573400_CIT0012","doi-asserted-by":"crossref","first-page":"R299","DOI":"10.1152\/ajpregu.00057.2007","article-title":"Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat","volume":"293","author":"McCafferty","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"3","key":"2020022511493573400_CIT0013","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jc.2017-02195","article-title":"Retosiban prevents stretch-induced human myometrial contractility and delays labor in cynomolgus monkeys","volume":"103","author":"Aye","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2020022511493573400_CIT0014","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bcp.12646","article-title":"Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study","volume":"80","author":"Thornton","year":"2015","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"2020022511493573400_CIT0015","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.bjp.0703892","article-title":"G(q\/11) and G(i\/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype","volume":"132","author":"Akam","year":"2001","journal-title":"Br J Pharmacol."},{"issue":"1","key":"2020022511493573400_CIT0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(97)01556-2","article-title":"Specific G protein activation and mu\u2013opioid receptor internalization caused by morphine, DAMGO and endomorphin I","volume":"342","author":"Burford","year":"1998","journal-title":"Eur J Pharmacol."},{"issue":"1","key":"2020022511493573400_CIT0017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/abio.1993.1473","article-title":"Analysis of receptor\u2013stimulated and basal guanine nucleotide binding to membrane G proteins by sodium dodecyl sulfate\u2013polyacrylamide gel electrophoresis","volume":"214","author":"Friedman","year":"1993","journal-title":"Anal Biochem."},{"issue":"6","key":"2020022511493573400_CIT0018","first-page":"988","article-title":"Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine\u2013mediated inositol phosphate formation","volume":"48","author":"Wang","year":"1995","journal-title":"Mol Pharmacol."},{"key":"2020022511493573400_CIT0019","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem."},{"issue":"6","key":"2020022511493573400_CIT0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0002-9378(84)90677-X","article-title":"Oxytocin receptors in the human uterus during pregnancy and parturition","volume":"150","author":"Fuchs","year":"1984","journal-title":"Am J Obstet Gynecol."},{"issue":"4538","key":"2020022511493573400_CIT0021","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.6278592","article-title":"Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor","volume":"215","author":"Fuchs","year":"1982","journal-title":"Science."},{"issue":"7","key":"2020022511493573400_CIT0022","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/bph.12198","article-title":"Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist GSK557296: a multi-level site of action","volume":"169","author":"Cl\u00e9ment","year":"2013","journal-title":"Br J Pharmacol."},{"issue":"2","key":"2020022511493573400_CIT0023","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1021\/jm201287w","article-title":"Pyridyl\u20132,5\u2013diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency","volume":"55","author":"Borthwick","year":"2012","journal-title":"J Med Chem."},{"issue":"1","key":"2020022511493573400_CIT0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-5381.1991.tb12374.x","article-title":"CP\u201393,129, a potent and selective 5\u2013HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater","volume":"104","author":"Matsubara","year":"1991","journal-title":"Br J Pharmacol."},{"issue":"5","key":"2020022511493573400_CIT0025","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2011.01425.x","article-title":"Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium","volume":"164","author":"Brighton","year":"2011","journal-title":"Br J Pharmacol."},{"issue":"3","key":"2020022511493573400_CIT0026","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1991.tb12486.x","article-title":"Salmeterol, a novel, long\u2013acting beta 2\u2013adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo","volume":"104","author":"Ball","year":"1991","journal-title":"Br J Pharmacol."},{"issue":"1","key":"2020022511493573400_CIT0027","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2006-956775","article-title":"Regulation of oxytocin receptors and oxytocin receptor signaling","volume":"25","author":"Blanks","year":"2007","journal-title":"Semin Reprod Med."}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqz043\/31730631\/bqz043.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/161\/2\/bqz043\/32648768\/bqz043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/161\/2\/bqz043\/32648768\/bqz043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T16:50:06Z","timestamp":1582649406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqz043\/5697361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqz043","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2020,1,7]]},"article-number":"bqz043"}}